Raloxifene [orch, phsu]
MODIFY [ftcn]
Insulin Sensitivity [patf]
glucose metabolism [moft]
postmenopausal [tmco]
Women [popg]
Insulin Sensitivity [patf]
Glucose tolerance [phsf]
Lipid Metabolism [moft]
investigated [ftcn]
postmenopausal [tmco]
Women [popg]
months [tmco]
treatment [ftcn]
Raloxifene [orch, phsu]
mg/d [qnco]
placebo [topp]
Group [idcn]
Women [popg]
N NOS [aapp, imft]
glucose metabolism [moft]
Evaluated [ftcn]
Oral Glucose Tolerance Test [diap]
75 g [qnco]
Group [idcn]
Women [popg]
N NOS [aapp, imft]
Sensitivity [qnco]
Peripheral [spco]
Glucose [bacs, carb, phsu]
utilization [ftcn]
Dependent [qlco]
Insulin [aapp, horm, phsu]
Evaluated [ftcn]
Frequently [tmco]
sampled [diap]
Glucose tolerance test [diap]
Minimal [qlco]
Metabolic [ftcn]
Modification [ftcn]
Observed [ftcn]
Women [popg]
Receive [qlco]
placebo [topp]
Raloxifene [orch, phsu]
MODIFY [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Decreased [qnco]
Low Density Lipoprotein Cholesterol [bacs, strd]
MMOLE [qnco]
liter [qnco]
MMOLE [qnco]
liter [qnco]
P NOS [aapp, imft]
0.014" [qnco]
Low Density Lipoprotein Cholesterol [bacs, strd]
High density lipoprotein [aapp, bacs, lipd]
Ratio [qnco]
MMOLE [qnco]
liter [qnco]
MMOLE [qnco]
liter [qnco]
P NOS [aapp, imft]
0.012" [qnco]
Fasting [fndg]
Levels [qlco]
responses [orga]
Oral Glucose Tolerance Test [diap]
Glucose [bacs, carb, phsu]
Insulin [aapp, horm, phsu]
C-Peptide [aapp, bacs]
C-Peptide [aapp, bacs]
Insulin [aapp, horm, phsu]
Modified [ftcn]
Raloxifene [orch, phsu]
Raloxifene [orch, phsu]
MODIFY [ftcn]
Sensitivity [qnco]
Insulin [aapp, horm, phsu]
Present [qnco]
postmenopausal [tmco]
Women [popg]
Raloxifene [orch, phsu]
Low density lipoprotein [aapp, bacs, lipd]
MODIFY [ftcn]
Insulin Sensitivity [patf]
glucose metabolism [moft]
